Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4080731 | 0.98 | HSD17B1 (0.42) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL4074215 | 0.94 | ESR2 (0.41) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL11992114 | 0.92 | CYP1A1 (0.40) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL13085146 | 0.90 | HDAC4 (0.40) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL14226906 | 0.90 | ENPP1 (0.40) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL11992216 | 0.90 | CYP1A1 (0.39) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL3220300 | 0.89 | CYP2A6 (0.39) | HDAC4HDAC2HDAC8GSTP1GPR84 | |
| SCHEMBL13430423 | 0.89 | ESR2 (0.51) | HDAC4HDAC2HDAC8HSD17B1HSD17B2 | |
| SCHEMBL13854881 | 0.89 | TNF (0.48) | ADORA2AADORA1MET | |
| SCHEMBL21643664 | 0.89 | MCL1 (0.43) | HDAC4HDAC2HDAC8GSTP1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2085371-B1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE USING THE FLUORANTHENE COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | IDEMITSU KOSAN CO (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-9120748-B2 | Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| EP-2085371-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE USING THE FLUORANTHENE COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION | Idemitsu Kosan Co., Ltd. (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | LEF1, ESD, AFF2 | HDAC4 4663/4885HDAC2 3870/4885HDAC8 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.